International Stem Cell (ISCO, $0.08) was a top loser this month, diving -1 to $0.08 per share. Of the 856 stocks analyzed in the Biotechnology Industry throughout this month, of them (3) exhibited an Uptrend while of them (6) were in a Downtrend. A.I.dvisor found 457 similar cases when ISCO's price dropped within one month. In out of those 457 cases, ISCO's price continued to decline in the subsequent month. Based on this historical data, A.I. thinks the odds of a Downtrend continuation for ISCO are